Ann E. McCullough

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

Martine Piccart, Eileen Holmes, José Baselga et al. · Journal of Clinical Oncology · 2015 · 370 citations · Full text

Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma

Mitesh J. Borad, Mia D. Champion, Jan B. Egan et al. · PLoS Genetics · 2014 · 334 citations · Full text

Fgfr Inhibitors, Pathology, Sporadic Intrahepatic Cholangiocarcinoma +19

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

Bradon R. McDonald, Tania Contente‐Cuomo, Stephen‐John Sammut et al. · Science Translational Medicine · 2019 · 304 citations · Full text

Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial

Edith A. Perez, E. Aubrey Thompson, Karla V. Ballman et al. · Journal of Clinical Oncology · 2015 · 200 citations · Full text

Androgen Receptor-Positive Triple Negative Breast Cancer: A Unique Breast Cancer Subtype

Lee J. McGhan, Ann E. McCullough, Cheryl Protheroe et al. · Annals of Surgical Oncology · 2013 · 165 citations

Breast Oncology, Medicine, Pathology +5